Clinical Guideline Highlights for the Hospitalist: Therapeutic Monitoring of Vancomycin.

Icon for Frontline Medical Communications Inc Related Articles

Clinical Guideline Highlights for the Hospitalist: Therapeutic Monitoring of Vancomycin.

J Hosp Med. 2020 Nov 18;:

Authors: Murphy M, Girdwood ST, Scheetz MH

Abstract
GUIDELINE TITLE: Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists RELEASE DATE: Online: March 19, 2020 PRIOR VERSION: 2009 DEVELOPERS: American Society of Health-System Pharmacists (ASHP), the Infectious Diseases Society of America (IDSA), the Pediatric Infectious Diseases Society (PIDS), and the Society of Infectious Diseases Pharmacists (SIDP) FUNDING SOURCE: ASHP, IDSA, PIDS, SIDP TARGET POPULATION: Adults, children, and neonates treated for documented or presumed methicillin-resistant Staphylococcus aureus infection.

PMID: 33231544 [PubMed - as supplied by publisher]